Innogent Pharmaceuticals Private Limited
About Innogent Pharmaceuticals Private Limited
Data last updated:
Innogent Pharmaceuticals Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 04 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24232MH2016PTC273875.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mubeen Ahmad Khan and Rumana Mubeen Khan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H – 2/0:1 Ground Floor Panchdeep Society Sector – 29 Vashi, Navi Mumbai, Maharashtra, India – 400703.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.01 Lakh. For the same year it recorded a net profit of ₹5.76 Lakh (net margin 95.9%) and EBITDA of ₹5.76 Lakh (EBITDA margin 95.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH – 2/0:1 Ground Floor Panchdeep Society Sector – 29 Vashi, Navi Mumbai, Maharashtra, India – 400703
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Innogent Pharmaceuticals Private Limited
The main business activity of Innogent Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Innogent Pharmaceuticals Private Limited FY 2025 filings available
Innogent Pharmaceuticals Private Limited reported revenue of ₹6.01 Lakh for FY 2025.
Financial Statement Summary of Innogent Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.76 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.76 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Innogent Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 95.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 95.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Innogent Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Innogent Pharmaceuticals Private Limited
Innogent Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mubeen Ahmad Khan | Director | 04 Mar 2016 | 10 Years 7 Months | Current |
| Rumana Mubeen Khan | Director | 04 Mar 2016 | 10 Years 7 Months | Current |
Peer Comparison of Innogent Pharmaceuticals Private Limited
Innogent Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nishant Pharmaceuticals Private Limited | ₹6.07 Lakh (FY 2022) | •••• | •••• | -60.0% | •••• | Mohali, Punjab, India |
| Octogena Pharmaceuticals Private Limited | ₹6.04 Lakh (FY 2025) | •••• | •••• | -35.0% | •••• | Solapur North, Maharashtra, India |
| Caelum Pharmaceuticals Private Limited | ₹6.01 Lakh (FY 2024) | •••• | •••• | -17.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Rexha Pharmaceuticals Private Limited | ₹6.01 Lakh (FY 2025) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Sandro Bio Pharmaceuticals Private Limited | ₹6.01 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Chennai, Tamil Nadu, India |
| Innogent Pharmaceuticals Private Limited this company | ₹6.01 Lakh (FY 2025) | •••• | •••• | •••• | Navi Mumbai, Maharashtra, India | |
| Krishicon Pharmaceuticals Private Limited | ₹6 Lakh (FY 2025) | •••• | •••• | -43.0% | •••• | Thane, Maharashtra, India |
| Novarance Pharmaceuticals Private Limited | ₹6 Lakh (FY 2025) | •••• | •••• | 73.0% | •••• | Mirzapur, Uttar Pradesh, India |
| Felding Roth Pharmaceuticals Private Limited | ₹5.96 Lakh (FY 2025) | •••• | •••• | -13.0% | •••• | Lucknow, Uttar Pradesh, India |
| Zisel Pharmaceuticals Private Limited | ₹5.96 Lakh (FY 2020) | •••• | •••• | 5830.0% | •••• | Varanasi, Uttar Pradesh, India |
| Riedeli Pharmaceuticals Private Limited | ₹5.95 Lakh (FY 2024) | •••• | •••• | -1.0% | •••• | Allahabad, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Innogent Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Innogent Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Innogent Pharmaceuticals Private Limited
Innogent Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Innogent Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Innogent Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Innogent Pharmaceuticals Private Limited
Innogent Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Mubeen Ahmad Khan was appointed as Director on 04 Mar 2016.
Credit Ratings, Litigation & Regulatory Alerts for Innogent Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Innogent Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Innogent Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Innogent Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Innogent Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Innogent Pharmaceuticals Private Limited
Innogent Pharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 04 March 2016 (10+ years old) and is registered under CIN U24232MH2016PTC273875.
Innogent Pharmaceuticals reported revenue of ₹6.01 Lakh for FY 2025.
Innogent Pharmaceuticals has 2 current directors:
- Mubeen Ahmad Khan - Director
- Rumana Mubeen Khan - Director
Innogent Pharmaceuticals reported a net profit of ₹5.76 Lakh (net margin 95.9%) and EBITDA of ₹5.76 Lakh (EBITDA margin 95.9%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Innogent Pharmaceuticals is U24232MH2016PTC273875. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innogent Pharmaceuticals was incorporated on 04 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Innogent Pharmaceuticals by revenue are Nishant Pharmaceuticals Private Limited, Octogena Pharmaceuticals Private Limited, Caelum Pharmaceuticals Private Limited, Rexha Pharmaceuticals Private Limited, Sandro Bio Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Mubeen Ahmad Khan was appointed as Director on 04 Mar 2016. Rumana Mubeen Khan was appointed as Director on 04 Mar 2016.
The registered office of Innogent Pharmaceuticals is at H – 20:1 Ground Floor Panchdeep Society Sector – 29 Vashi, Navi Mumbai, Maharashtra, India – 400703.
Innogent Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Innogent Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.